Latvian State Drug Agency and Health Inspectorate with a special permit released newly produced batch of RIGVIR medicine for sale in Latvia, so RIGVIR is now available again for patients in Latvia. At the same time registration of Rigvir in Latvia is now temporarily postponed in order to ensure improvements in validation of the new testing methods of RIGVIR in accordance with State Drug Agency requirements.
Meanwhile, Rigvir is also available for patients interested in this kind of oncolytic virotherapy in other countries where RIGVIR obtained national registrations. Medicine is registered in Georgia, Armenia and Uzbekistan and these registrations are in power and not being compromised.
Jumeirah Lake Towers
Swiss Tower, office 204
P.O. Box 309073, Dubai, UAE
© 2020 International Virotherapy Center Limited. All Rights Reserved